Literature DB >> 23981745

National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China.

Rong Mu1, Chun Li, Jia-Xin Zhu, Xiao-Ying Zhang, Tian-Jiao Duan, Min Feng, Guo-Chun Wang, Feng-Chun Zhang, Zhan-Guo Li.   

Abstract

AIM: Fibromyalgia (FM) is a chronic disorder characterized by widespread musculoskeletal pain and fatigue. It is a less frequently diagnosed disease in China, thus Chinese rheumatologists may have lower awareness of FM compared with colleagues in Western countries. The aim of this study is to investigate the perceptions of FM in Chinese rheumatologists and analyze their therapeutic approach in clinical practice.
METHOD: An anonymous questionnaire survey was conducted among a nationwide sample of Chinese rheumatologists at the 15th National Rheumatology Conference in 2010. The 20-question survey included questions regarding background, work experience, perceptions of diagnosis and behaviors of treatment related to FM. Continuing medical education (CME) information was also collected in the survey.
RESULTS: Seven hundred and seven rheumatologists responded to the questionnaire, a response rate of 60%. Less than one-fifth of the respondents were experienced in dealing with FM. Although most of the respondents regarded FM as a distinct pathological entity, nearly 30% of Chinese rheumatologists believed that FM was only a psychological disorder. The respondents recognized some of the FM-related symptoms, but had limited knowledge on the diagnostic criteria. Eighty percent of the respondents declared they had difficulties in treating FM patients. However, nearly all (90.8%) respondents believed that the prognosis of FM patients was usually benign. Our data also showed that most Chinese rheumatologists were eager for CME on FM.
CONCLUSION: The awareness and perception of FM are still low among Chinese rheumatologists. CME on FM is needed for improving the quality of health care in China.
© 2013 The Authors International Journal of Rheumatic Diseases © 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  awareness; fibromyalgia; perception

Mesh:

Year:  2013        PMID: 23981745     DOI: 10.1111/1756-185X.12055

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  6 in total

1.  [Validation of the Pollard' s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia].

Authors:  C Gao; L H Chen; L Wang; H Yao; X W Huang; Y B Jia; T Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18

2.  Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample.

Authors:  Ying Zhang; Dongfeng Liang; Ronghuan Jiang; Xiaojian Ji; Yiwen Wang; Jian Zhu; Jianglin Zhang; Feng Huang
Journal:  Clin Rheumatol       Date:  2017-10-13       Impact factor: 2.980

3.  Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects.

Authors:  Xiao Zhang; Huji Xu; Zhiyi Zhang; Yang Li; Lynne Pauer; Shanmei Liao; Fengchun Zhang
Journal:  J Pain Res       Date:  2021-02-25       Impact factor: 3.133

4.  Knowledge, Awareness, and Perceptions of the Diagnosis and Management of Fibromyalgia Among Physical Therapists in Saudi Arabia: A Cross-Sectional Survey.

Authors:  Faris Alodiabi; Ahmed Alhowimel; Mazyad Alotaibi; Dalyah Alamam; Julie M Fritz
Journal:  Open Access Rheumatol       Date:  2020-11-30

5.  Diagnosis and Treatment of Five Pain-Related Conditions in Urban China: A Population-Based Cross-Sectional National Health and Wellness Survey.

Authors:  Bifa Fan; Shuiqing Li; Baishan Wu; Jinghua Zhang; Jing Zhou
Journal:  J Pain Res       Date:  2022-06-23       Impact factor: 2.832

6.  Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field.

Authors:  Lesley M Arnold; Ernest Choy; Daniel J Clauw; Don L Goldenberg; Richard E Harris; Milton Helfenstein; Troels Staehelin Jensen; Koichi Noguchi; Stuart L Silverman; Takahiro Ushida; Guochun Wang
Journal:  Clin J Pain       Date:  2016-09       Impact factor: 3.442

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.